The multifunctional protein PEA-15 is involved in the control of apoptosis and cell cycle in astrocytes.

PEA-15 is a small protein (15 kDa) that was first identified as an abundant phosphoprotein in brain astrocytes [Araujo et al., J Biol Chem 1993;268(8):5911-20], and subsequently shown to be widely expressed in different tissues and highly conserved among mammals [Estelles et al., J Biol Chem 1996;271(25):14800-6; Danziger et al., J Neurochem 1995;64(3):1016-25]. It is composed of a N-terminal death effector domain and a C-terminal tail of irregular structure. PEA-15 is regulated by multiple calcium-dependent phosphorylation pathways that account for its different forms: a non-phosphorylated form in equilibrium with a mono and a biphosphorylated variety. This already suggested that PEA-15 may play a major role in signal integration. Accordingly, it has been demonstrated to modulate signaling pathways that control apoptosis and cell proliferation. In particular, PEA-15 diverts astrocytes from TNFalpha-triggered apoptosis and regulates the actions of the ERK MAP kinase cascade by binding to ERK and altering its subcellular localization. The three-dimensional structure of PEA-15 has been modelized and recently determined using NMR spectroscopy, and may help to understand the various functions played by the protein through its molecular interactions.

[1]  K. Vogan,et al.  Identification of a novel, alternatively spliced isoform and single nucleotide polymorphisms in the murine Pea-15 gene , 2001, Mammalian Genome.

[2]  R. Masgrau,et al.  Involvement of ETA and ETB receptors in the activation of phospholipase D by endothelins in cultured rat cortical astrocytes , 1998 .

[3]  T. Jensen,et al.  PLD2 Complexes with the EGF Receptor and Undergoes Tyrosine Phosphorylation at a Single Site upon Agonist Stimulation* , 1998, The Journal of Biological Chemistry.

[4]  A. Chawla,et al.  A Role for Phospholipase D in GLUT4 Glucose Transporter Translocation* , 2000, The Journal of Biological Chemistry.

[5]  J. Ramos,et al.  Regulation of Expression of Phospholipase D1 and D2 by PEA-15, a Novel Protein That Interacts with Them* , 2000, The Journal of Biological Chemistry.

[6]  J. Tschopp,et al.  Defective death receptor signaling as a cause of tumor immune escape. , 2002, Seminars in cancer biology.

[7]  Matthias Mann,et al.  FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex , 1996, Cell.

[8]  W. Kuo,et al.  Assignment of HMAT1, the human homolog of the murine mammary transforming gene (MAT1) associated with tumorigenesis, to 1q21.1, a region frequently gained in human breast cancers. , 1997, Genomics.

[9]  E. Formstecher,et al.  PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. , 2001, Developmental cell.

[10]  J. Merrill,et al.  Cytokines in inflammatory brain lesions: helpful and harmful , 1996, Trends in Neurosciences.

[11]  S. Gregory,et al.  Comparative Physical and Transcript Maps of ∼1 Mb around loop-tail, a Gene for Severe Neural Tube Defects on Distal Mouse Chromosome 1 and Human Chromosome 1q22–q23 , 2001 .

[12]  S. Miyamoto,et al.  Identification of a mammary transforming gene (MAT1) associated with mouse mammary carcinogenesis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  V. Dixit,et al.  Death receptors: signaling and modulation. , 1998, Science.

[14]  Erwin G. Van Meir,et al.  Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells. , 2001, Cancer research.

[15]  E. Formstecher,et al.  Keeping TNF-induced apoptosis under control in astrocytes: PEA-15 as a 'double key' on caspase-dependent and MAP-kinase-dependent pathways. , 2001, Progress in brain research.

[16]  S. Fesik,et al.  Insights into Programmed Cell Death through Structural Biology , 2000, Cell.

[17]  T. Soderling,et al.  A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1 , 1996, Molecular and cellular biology.

[18]  J. Pouysségur,et al.  Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. , 2002, European journal of biochemistry.

[19]  J. Girault,et al.  Endothelin Induces a Calcium‐Dependent Phosphorylation of PEA‐15 in Intact Astrocytes: Identification of Ser104 and Ser116 Phosphorylated, Respectively, by Protein Kinase C and Calcium/Calmodulin Kinase II In Vitro , 1998, Journal of neurochemistry.

[20]  Junying Yuan,et al.  Human ICE/CED-3 Protease Nomenclature , 1996, Cell.

[21]  J. Bertin,et al.  Binding of FADD and Caspase-8 to Molluscum Contagiosum Virus MC159 v-FLIP Is Not Sufficient for Its Antiapoptotic Function , 2002, Journal of Virology.

[22]  J. Ramos,et al.  The Death Effector Domain of PEA-15 Is Involved in Its Regulation of Integrin Activation* , 1998, The Journal of Biological Chemistry.

[23]  C. Bogardus,et al.  Molecular characterization of the human PEA15 gene on 1q21-q22 and association with type 2 diabetes mellitus in Pima Indians. , 2000, Gene.

[24]  S. Nakashima,et al.  Possible role of phospholipase D in cellular differentiation and apoptosis. , 1999, Chemistry and physics of lipids.

[25]  J. Glowinski,et al.  Characterization of PEA-15, a major substrate for protein kinase C in astrocytes. , 1993, The Journal of biological chemistry.

[26]  P. Marin,et al.  Are Several G Proteins Involved in the Different Effects of Endothelin‐1 in Mouse Striatal Astrocytes? , 1991, Journal of neurochemistry.

[27]  K. Khalili,et al.  Transcriptional regulation: lessons from the human neurotropic polyomavirus, JCV. , 1995, Virology.

[28]  F. Andreozzi,et al.  PED/PEA‐15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus , 1998, The EMBO journal.

[29]  F. Beguinot,et al.  Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Death-inducing Signaling Complex and Its Modulation by c-FLIP and PED/PEA-15 in Glioma Cells* , 2002, The Journal of Biological Chemistry.

[30]  G. W. Peet,et al.  Novel NEMO/IκB Kinase and NF-κB Target Genes at the Pre-B to Immature B Cell Transition* , 2001, The Journal of Biological Chemistry.

[31]  M. H. Werner,et al.  Recognition of ERK MAP kinase by PEA‐15 reveals a common docking site within the death domain and death effector domain , 2002, The EMBO journal.

[32]  J. Glowinski,et al.  Cellular Expression, Developmental Regulation, and Phylogenic Conservation of PEA‐15, the Astrocytic Major Phosphoprotein and Protein Kinase C Substrate , 1995, Journal of neurochemistry.

[33]  J. Glowinski,et al.  Knock-Out of the Neural Death Effector Domain Protein PEA-15 Demonstrates That Its Expression Protects Astrocytes from TNFα-Induced Apoptosis , 1999, The Journal of Neuroscience.

[34]  J. Antel,et al.  Fas expression on human fetal astrocytes without susceptibility to fas-mediated cytotoxicity , 1998, Neuroscience.

[35]  C. Pilarsky,et al.  Differential gene expression by endothelial cells in distinct angiogenic states. , 2000, European journal of biochemistry.

[36]  G. Condorelli,et al.  PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis , 1999, Oncogene.

[37]  J. Glowinski,et al.  The Major Astrocytic Phosphoprotein PEA-15 Is Encoded by Two mRNAs Conserved on Their Full Length in Mouse and Human* , 1996, The Journal of Biological Chemistry.

[38]  F. Martinon,et al.  NALPs: a novel protein family involved in inflammation , 2003, Nature Reviews Molecular Cell Biology.

[39]  M. Cobb,et al.  Activation of mitogen-activating protein kinase by glucose is not required for insulin secretion. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[40]  B. Hemmings,et al.  Serine/threonine protein phosphatases. , 1995, The Biochemical journal.

[41]  E. Formstecher,et al.  Death effector domain protein PEA-15 potentiates Ras activation of extracellular signal receptor-activated kinase by an adhesion-independent mechanism. , 2000, Molecular biology of the cell.

[42]  Stephen W. Fesik,et al.  NMR structure and mutagenesis of the FADD (Mort1) death-effector domain , 1998, Nature.

[43]  E. Ellis,et al.  Effect of Ca2+ on In Vitro Astrocyte Injury , 1997, Journal of neurochemistry.

[44]  David Wallach,et al.  Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell Death , 1996, Cell.

[45]  W. Roa,et al.  Calcium/Calmodulin-dependent Protein Kinase II Regulation of c-FLIP Expression and Phosphorylation in Modulation of Fas-mediated Signaling in Malignant Glioma Cells* , 2003, The Journal of Biological Chemistry.